PLA2G12A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29189992037482E-10 |
Normal-vs-Stage2 |
1.146400E-02 |
Normal-vs-Stage3 |
1.71662684067542E-12 |
Normal-vs-Stage4 |
1.22124532708767E-14 |
Stage1-vs-Stage2 |
6.421600E-01 |
Stage1-vs-Stage3 |
1.303390E-03 |
Stage1-vs-Stage4 |
4.4209999999989E-05 |
Stage2-vs-Stage3 |
3.535600E-02 |
Stage2-vs-Stage4 |
6.884500E-03 |
Stage3-vs-Stage4 |
3.402400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.22044604925031E-16 |
Normal-vs-AfricanAmerican |
1.57626999999216E-05 |
Normal-vs-Asian |
4.03859999997813E-06 |
Caucasian-vs-AfricanAmerican |
6.514200E-01 |
Caucasian-vs-Asian |
4.582600E-01 |
AfricanAmerican-vs-Asian |
3.285400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
8.19880052738142E-10 |
Male-vs-Female |
4.158100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.639310E-04 |
Normal-vs-Age(41-60Yrs) |
4.43245440351347E-12 |
Normal-vs-Age(61-80Yrs) |
1.65023550380283E-12 |
Normal-vs-Age(81-100Yrs) |
2.277300E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.793800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.159400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.761200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.198400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.370800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.689600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.888200E-02 |
Normal-vs-Grade 2 |
1.09359999944658E-08 |
Normal-vs-Grade 3 |
2.22044604925031E-15 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
9.265200E-01 |
Grade 1-vs-Grade 3 |
3.471000E-01 |
Grade 1-vs-Grade 4 |
1.460360E-02 |
Grade 2-vs-Grade 3 |
2.650000E-02 |
Grade 2-vs-Grade 4 |
1.98679999996454E-06 |
Grade 3-vs-Grade 4 |
6.237600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.62789814750886E-11 |
Normal-vs-ccB subtype |
7.35520000461065E-08 |
ccA subtype-vs-ccB subtype |
8.610200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.88862292261183E-13 |
Normal-vs-N1 |
1.658750E-03 |
N0-vs-N1 |
2.634000E-01 |
|
|